<DOC>
	<DOCNO>NCT01928693</DOCNO>
	<brief_summary>This Phase II study evaluate safety efficacy three fluoroquinolone ophthalmic agent determine optimal treatment patient infectious corneal ulcer .</brief_summary>
	<brief_title>A Comparison Three Fluoroquinolone Topical Eyedrops Treatment Infectious Corneal Ulcers .</brief_title>
	<detailed_description>This prospective , single mask , comparative , mono-therapeutic trial evaluate three fluoroquinolone agent approve marketed treatment conjunctivitis . Approximately 120 patient corneal ulcer great 2 mm less 6 mm size meet inclusion criterion enrol study . Patients randomize 2:1:1 ratio receive besifloxacin 0.6 % ophthalmic suspension , gatifloxacin 0.5 % ophthalmic solution , moxifloxacin 0.5 % ophthalmic solution .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Corneal Ulcer</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Gatifloxacin</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>7- ( 3-aminohexahydro-1H-azepin-1-yl ) -8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>1 . Patients must age 1890 year age . 2 . Patients must able understand nature study , give write informed consent prior study entry , comply study requirement . 3 . Patients must corneal ulcer great 2mm less 6mm size . 4 . Patients must corneal ulcer present one eye . 5 . Patients must agree wear contact lenses study . 1 . Patients multifocal ulcer . 2 . Signs viral fungal infection . 3 . Treatment antibiotic within 14 day study entry . 4 . Treatment systemic topical ocular antiviral agent systemic topical steroid topical ocular nonsteroidal antiinflammatory drug ( NSAIDS ) prior 14day period . 5 . Known hypersensitivity allergy steroid ( Loteprednol etabonate ) ingredient three study drug ( Besifloxacin 0.6 % Gatifloxacin 0.5 % Moxifloxacin 0.5 % ) . 6 . Contact lens spectacle available . 7 . Ocular surgery ( include laser surgery ) either eye within 6 week prior entry study . 8 . Participation investigational study within past 30 day . 9 . Pregnant woman , minor , able consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>infectious corneal ulcer</keyword>
</DOC>